2. Signaling Pathways
  3. Membrane Transporter/Ion Channel
  4. SLC39 (Zinc Transporter)
  5. SLC39 (Zinc Transporter) Inhibitor

SLC39 (Zinc Transporter) Inhibitor

SLC39 (Zinc Transporter) Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-P992159
    Anti-ZnT8 Antibody (mAb43)
    		Inhibitor
    Anti-ZnT8 Antibody (mAb43) is a monoclonal antibody targeting the zinc transporter ZnT8, with islet-specific biodistribution characteristics. Anti-ZnT8 Antibody (mAb43) binds to extracellular ZnT8 on the surface of pancreatic β-cells and masks its insulin-co-localizing sites to block autoimmune recognition. Anti-ZnT8 Antibody (mAb43) also promotes an increase in the proportion of regulatory T cells and inhibits B cell antigen presentation, thereby effectively blocking the T cell-mediated cascade of β-cell destruction. Anti-ZnT8 Antibody (mAb43) eliminates insulitis, preserves β-cell mass and induces seroconversion of autoantibodies, without directly altering the insulin secretion function or content of β-cells. Anti-ZnT8 Antibody (mAb43) can be used for research related to type 1 diabetes.
  • HY-P991145
    Laventatug
    		Inhibitor
    Laventatug is a humanized monoclonal antibody targeting human SLC39A6. Laventatug specifically binds to SLC39A6, interfering with the intracellular zinc ion transport process and thus exerting antitumor activity. Laventatug is promising for research of cancers.